Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.verified

OLMA

Price:

$11.86

Market Cap:

$679.18M

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.[Read more]

Industry

Biotechnology

IPO Date

2020-11-19

Stock Exchange

NASDAQ

Ticker

OLMA

The Enterprise Value as of November 2024 (TTM) for Olema Pharmaceuticals, Inc. (OLMA) is 664.25M

According to Olema Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 664.25M. This represents a change of 14.09% compared to the average of 582.23M of the last 4 quarters.

Olema Pharmaceuticals, Inc. (OLMA) Historical Enterprise Value (quarterly & annually)

How has OLMA Enterprise Value performed in the past?

The mean historical Enterprise Value of Olema Pharmaceuticals, Inc. over the last ten years is 823.14M. The current 664.25M Enterprise Value has changed 7.97% with respect to the historical average. Over the past ten years (40 quarters), OLMA's Enterprise Value was at its highest in in the September 2020 quarter at 1.71B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

823.14M

Median

628.19M

Minimum

76.85M

Maximum

1.97B

Olema Pharmaceuticals, Inc. (OLMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Olema Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 639.99%

Maximum Annual Enterprise Value = 1.97B

Minimum Annual Increase = -94.46%

Minimum Annual Enterprise Value = 76.85M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023568.69M639.99%
202276.85M-10.62%
202185.99M-94.46%
20201.55B-21.18%
20191.97B186.22%

Olema Pharmaceuticals, Inc. (OLMA) Average Enterprise Value

How has OLMA Enterprise Value performed in the past?

The current Enterprise Value of Olema Pharmaceuticals, Inc. (OLMA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

243.84M

5-year avg

850.23M

10-year avg

823.14M

Olema Pharmaceuticals, Inc. (OLMA) Enterprise Value vs. Peers

How is OLMA’s Enterprise Value compared to its peers?

Olema Pharmaceuticals, Inc.’s Enterprise Value is less than Sana Biotechnology, Inc. (796.24M), less than Cullinan Oncology, Inc. (810.70M), greater than aTyr Pharma, Inc. (138.44M), greater than Zentalis Pharmaceuticals, Inc. (272.28M), greater than Molecular Partners AG (57.25M), greater than Mineralys Therapeutics, Inc. (603.45M), greater than AN2 Therapeutics, Inc. (5.46M), less than Pharvaris N.V. (844.28M), greater than PepGen Inc. (174.61M), less than Gracell Biotechnologies Inc. (5.47B), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Monte Rosa Therapeutics, Inc. (478.04M), greater than Design Therapeutics, Inc. (258.23M), less than Erasca, Inc. (691.95M), less than Disc Medicine, Inc. (1.23B), greater than Larimar Therapeutics, Inc. (453.31M), greater than Fennec Pharmaceuticals Inc. (113.94M), greater than Orchestra BioMed Holdings, Inc. (184.26M), greater than Nuvectis Pharma, Inc. (99.58M), less than Centessa Pharmaceuticals plc (1.76B),

Build a custom stock screener for Olema Pharmaceuticals, Inc. (OLMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Olema Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Olema Pharmaceuticals, Inc. (OLMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Olema Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Olema Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Olema Pharmaceuticals, Inc. (OLMA)?

What is the 3-year average Enterprise Value for Olema Pharmaceuticals, Inc. (OLMA)?

What is the 5-year average Enterprise Value for Olema Pharmaceuticals, Inc. (OLMA)?

How does the current Enterprise Value for Olema Pharmaceuticals, Inc. (OLMA) compare to its historical average?